Related Experiment Video
Updated: Aug 13, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
Cutaneous sarcoidosis in a patient with Philadelphia-positive chronic myelogenous leukemia treated with
L L Yavorkovsky1, G Carrum, S Bruce
1Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
Abstract:
A patient with Philadelphia-positive (Ph+) chronic myelogenous leukemia (CML) was diagnosed with cutaneous sarcoidosis after treatment with interferon-alpha (IFN-alpha). Following IFN-alpha dose reduction, the skin lesions disappeared. Few cases of sarcoidosis associated with IFN treatment have been reported, and only in one patient with pre-existing CML. Our patient was unique in that (1) the sarcoidosis was induced by the IFN-alpha treatment alone, (2) it developed de novo, and (3) it was confined to the skin.

